
German Health Ministry to invest €6.2bn in vaccines
With the request to the national budget committee, which will decide on it tomorrow, Germany more than doubles the amount of money to be invested...

Oxular Ltd raises US$37m
Oxford-based Oxular said it will use the proceeds to finance Phase II studies evaluatingO the company’s lead asset, OXU-001, for the treatment of...

MosaMeat BV closes US$85m Series B financing
While EU policymakers are yet discussing the green deal or farm to fork strategies, Dutch MosaMeat BV is launching a new era of biotechnologically...

German antibodies in demand in USA
Initially, Seattle-based Just - Evotec Biologics will receive US$28.6m from the Defense Health Agency ("DHA") under a partnership announced...

V-Bio Ventures launches second fund at €78m
With the investment, the Belgian biotech sector gets a cash injection. According to V-Bio Ventures, the new fund will build on the investment...

Servier and MiNA Therapeutics sign €220m deal
Under the agreement, MiNA Therapeutics will use its small activating RNA platform (saRNA) to identify candicate saRNAs that can restore normal cell...